FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder ( www.nbcnews.com )
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B who meet certain requirements....
The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B who meet certain requirements....